Pfizer Inc PFE:NYSE (Common Stock)

LastDaily Change / % ChangeDividend YieldVolumeAvg Volume (10 day)
34.26 0.20   0.59%3.74%24,711,95428.6M
Market data is delayed by at least 15 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 2/24/2017

Latest News Headlines for Pfizer Inc

Pfizer Prices $1,065,000,000 Debt Offering

NEW YORK--(BUSINESS WIRE)--February 24, 2017-- Pfizer Inc. (NYSE: PFE) today announced the pricing of $1,065,000,000 aggregate principal amount of 4.20% notes due 2047. This offering is expected to be sold to professional institutional investors in Taiwan, with application to be made to list the notes on the Taipei Exchange.

Ronald E. Blaylock Elected to Pfizer's Board of Directors

NEW YORK--(BUSINESS WIRE)--February 23, 2017-- Pfizer Inc. today announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately. Mr. Blaylock was also appointed to the Corporate Governance and Science and Technology Committees of Pfizer's Board.

Investors: Option reports for Advanced Micro Devices, Macy's Incorporated, Nike, Pfizer Inc. and Vipshop Holdings

CHICAGO, Feb. 22, 2017 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD, M, NKE, PFE, and VIPS. To see the high-return covered-call trades uncovered by InvestorsObserver's analysts, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

View more recent headlines

Peers Information HelpPFE Pfizer Inc vs. Peers

PFE
Pfizer Inc
5.48%
Roche Holding Ltd. (ADR)
7.26%
Novartis AG (ADR)
6.10%
Merck & Co., Inc.
12.38%
Bayer AG (ADR)
6.19%
PFE
Pfizer Inc
3.74%
Roche Holding Ltd. (ADR)
3.33%
Novartis AG (ADR)
3.52%
Merck & Co., Inc.
2.84%
Bayer AG (ADR)
2.59%
PFE
Pfizer Inc
0.59%
Roche Holding Ltd. (ADR)
0.20%
-0.22%
Novartis AG (ADR)
Merck & Co., Inc.
0.47%
-0.57%
Bayer AG (ADR)
Compare these stocks

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. The Company's segments include Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Its biopharmaceutical products include Lipitor, Sutent and the Premarin family of products. Its biotechnology products include BeneFIX, ReFacto and Xyntha. The Company's contract manufacturing business, Pfizer CentreOne, consists of its contract manufacturing and active pharmaceutical ingredient sales operation, including manufacturing and supply agreements with Zoetis Inc., and Hospira’s One-2-One sterile injectables contract manufacturing operation. Its research focuses on six areas, which include immunology and inflammation, cardiovascular and metabolic diseases, oncology, vaccines, neuroscience and pain, and rare diseases. The Company's subsidiaries include Hospira, Inc. and Medivation, Inc.

http://www.pfizer.com

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open34.17
Previous Close34.06
Day High34.35
Day Low33.99
52 Week High8/1/2016 | 37.39
52 Week Low3/17/2016 | 28.74
% Off 52 Week High-8.37%
% Off 52 Week Low19.21%
Beta (5 Yr)0.99
Volatility Avg2/24/2017 | 18.13
10-Day Avg. Volume28,608,692
Market data is delayed by at least 15 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)12/31/2016 | 1.17
P/E Ratio12/31/2016 | 29.4
Market CapMega Cap | 203.9B
Shares Outstanding5.95B
Float6.1B

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield3.74%
Ex-Date2/1/2017
Dividend Announcement12/12/2016
Date of Record2/3/2017
Payable$0.32 - QRTR
Payable Date3/1/2017

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short34.30M
Short Ratio1.2
Short % of Float0.57%
As of 1/31/2017
The performance data quoted represents past performance. Past performance does not guarantee future results. Current performance may be lower or higher than the performance quoted. Investment return and principal value of an investment will fluctuate and when redeemed, the investment may be worth more or less than their original cost.
The research, tools, and information provided will not include every security available to the public.